Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osten Ljunggren

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Calcified Tissue International|April 3, 2012
Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS)J Bernard Walsh, Willem F Lems, Dimitrios Karras, et al.
Calcified Tissue International|October 14, 2009
Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS)Bente L Langdahl, Gerald Rajzbaum, Franz Jakob, et al.
Bone|February 3, 2009
Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trialNeil Binkley, Johann D Ringe, John I Reed, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 4, 2008
Older men with low serum estradiol and high serum SHBG have an increased risk of fracturesDan Mellström, Liesbeth Vandenput, Hans Mallmin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 19, 2007
The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in menCharlotte Swanson, Dan Mellström, Mattias Lorentzon, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2007
Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in menLiesbeth Vandenput, Dan Mellström, Mattias Lorentzon, et al.
Current Medical Research and Opinion|December 25, 2007
Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community settingGerald Rajzbaum, Franz Jakob, Dimitrios Karras, et al.
Kidney International|June 10, 2010
Associations of estradiol and testosterone with serum phosphorus in older men: the Osteoporotic Fractures in Men studyJerry Meng, Claes Ohlsson, Gail A Laughlin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 26, 2009
Smoking predicts incident fractures in elderly men: Mr OS SwedenHans Jutberger, Mattias Lorentzon, Elizabeth Barrett-Connor, et al.
Obesity (Silver Spring, Md.)|February 2, 2008
IL6 and IL1B polymorphisms are associated with fat mass in older men: the MrOS Study SwedenLouise Strandberg, Dan Mellström, Osten Ljunggren, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Calcified Tissue International|April 3, 2012
Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS)J Bernard Walsh, Willem F Lems, Dimitrios Karras, et al.
Calcified Tissue International|October 14, 2009
Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS)Bente L Langdahl, Gerald Rajzbaum, Franz Jakob, et al.
Bone|February 3, 2009
Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trialNeil Binkley, Johann D Ringe, John I Reed, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 4, 2008
Older men with low serum estradiol and high serum SHBG have an increased risk of fracturesDan Mellström, Liesbeth Vandenput, Hans Mallmin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 19, 2007
The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in menCharlotte Swanson, Dan Mellström, Mattias Lorentzon, et al.
The Journal of Clinical Endocrinology and Metabolism|August 23, 2007
Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in menLiesbeth Vandenput, Dan Mellström, Mattias Lorentzon, et al.
Current Medical Research and Opinion|December 25, 2007
Characterization of patients in the European Forsteo Observational Study (EFOS): postmenopausal women entering teriparatide treatment in a community settingGerald Rajzbaum, Franz Jakob, Dimitrios Karras, et al.
Kidney International|June 10, 2010
Associations of estradiol and testosterone with serum phosphorus in older men: the Osteoporotic Fractures in Men studyJerry Meng, Claes Ohlsson, Gail A Laughlin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 26, 2009
Smoking predicts incident fractures in elderly men: Mr OS SwedenHans Jutberger, Mattias Lorentzon, Elizabeth Barrett-Connor, et al.
Obesity (Silver Spring, Md.)|February 2, 2008
IL6 and IL1B polymorphisms are associated with fat mass in older men: the MrOS Study SwedenLouise Strandberg, Dan Mellström, Osten Ljunggren, et al.
Pageof 9